Navigation Links
Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Date:8/26/2008

le at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.

Forward Looking Statement

Statements herein relating to future development results and performance, conditions or strategies and other matters, including expectations regarding product and clinical developments are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including risks relating to the early stage of Novavax's product candidates under development; current results may not be predictive of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we may develop; further testing is required before regulatory approval can be applied for and the FDA may not approve the pandemic vaccine even if further trial results are similar to those disclosed herein; uncertainties relating to clinical trials; dependence on the efforts of third parties; competition for clinical resources and patient enrollment from drug candidates in development by other companies with greater resources and visibility; and risks that we may lack the financial resources and access to capital to fund our operations including further clinical trials. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at http://www.sec.gov. These forward-looking statements speak only as of the date of this press release, a
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
2. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
3. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
4. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
5. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
6. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
7. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
8. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
9. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
10. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
11. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015  Dr. Yair Walzer ... resolve vaginal health issues often caused by menopause. The MonaLisa ... no anesthesia, received FDA clearance in 2014. Dr. Walzer is ... to offer the special fractional CO 2 laser ... cancer survivors. In 2010 there were greater ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. Drug delivery ... to other systems because of the anatomy and ... and nutrients to all organs of the body. ...
(Date:5/29/2015)... Massachusetts and SPARTANBURG, South Carolina ... The Guardian Research Network and Molecular Health have announced ... and molecular diagnostic decision support to the majority of ... Guardian Research Network will collaborate with Molecular Health to ... testing to identify cohorts from hundreds of thousands of ...
Breaking Medicine Technology:The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... Complete Accrual in Fourth Quarter 2008, BERKELEY ... Board: GNTA) announced the presentation of a,progress update ... (oblimersen,sodium) Injection, the Company,s lead oncology product, in ... a satellite investigator,s,meeting held in conjunction with the ...
... a Year; Studies ... Milestone Payment to Micromet, BETHESDA, Md., and ZURICH, Switzerland, ... today announced the initiation of,formal preclinical safety studies for the ... for the achievement,of this milestone., Under a 2007 agreement ...
Cached Medicine Technology:Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma 2Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma 3Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma 4Genta Updates Progress of its Phase 3 Trial of Genasense(R) in Patients with Advanced Melanoma 5Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 2Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 3Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases 4
(Date:5/29/2015)... Abington Hospital – Jefferson Health ... hospitals in the nation to join the ... and work toward achieving the Baby-Friendly USA© designation. ... on maternity care practices leading to Baby-Friendly designation. ... Prevention, EMPower is aimed at increasing breastfeeding rates ...
(Date:5/29/2015)... 29, 2015 According to a recent HealthDay ... full-time workers has a substance abuse problem - the data, ... 111,500 adults with full-time jobs, revealed that 9.5% of those ... year. (1) The National Council on Alcoholism and Drug Dependence ... and an estimated 70% of the 14.8 million illicit drug ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 To compile ... research, choosing systems that have several awards for clinical ... on what systems stood out to them in terms ... inclusion as well. , The 50 Great Health Systems ... Adventist Health System (Altamonte Springs, Fla.) , Advocate Health ...
(Date:5/29/2015)... New York, New York (PRWEB) May 29, 2015 ... and distributor of patented products, announces that it has ... Chat Room, a technology patent that aims to let ... various industry experts in real time. , "This is ... Expert Chat Room " said Scott J. Cooper, CEO ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Mediaplanet has ... to educate readers on the importance of proper sun ... within USA Today, with a circulation of approximately 250,000 ... digital component is distributed nationally, through a vast social ... sites and partner outlets. To explore the digital version ...
Breaking Medicine News(10 mins):Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5
... The Muscular Dystrophy Association today awarded 44 grants totaling ... of disease processes and to uncover new strategies for ... affecting more than a million Americans. The vital ... of the MDA Labor Day Telethon. "MDA-supported researchers ...
... DALLAS Feb. 8, 2011 The popular drug dutasteride ... in men who are at elevated risk of developing the ... researcher. In a study available in the January ... at an annual cost of $1,400, is impractical when compared ...
... one-half of U.S. adults who use the Internet participate ... not much is known about their quality and safety. ... networking websites targeting patients, researchers in the Children,s Hospital ... diabetes websites. Their audit found large variations ...
... University] Despite the intent of recent mental health ... reductions in co-pays for outpatient mental health care will ... seek that care, according to a new study by ... passed in 2008 and 2010, end an insurance industry ...
... quantities of data across different levels of detail, from ... of methods. Each method has its own type of ... across levels of detail and from different databases, for ... disease, is therefore challenging and time consuming. In addition, ...
... today in the European Heart Journal shows ... have long-term, serious health implications. Leading academics from ... heart attacks and cardiovascular disorders which often result in ... Warwick Medical School, explained: "If you sleep less ...
Cached Medicine News:Health News:MDA awards $13.5 million in grants for research treatments for neuromuscular diseases 2Health News:MDA awards $13.5 million in grants for research treatments for neuromuscular diseases 3Health News:MDA awards $13.5 million in grants for research treatments for neuromuscular diseases 4Health News:Dutasteride not a cost-effective way to prevent prostate cancer in some men 2Health News:Quality varies in social networking websites for diabetics 2Health News:Quality varies in social networking websites for diabetics 3Health News:Lower mental health co-pays do not help seniors seek care 2Health News:Major step taken toward an open and shared digital brain atlasing framework 2Health News:Late nights can lead to higher risk of strokes and heart attacks 2
... gives physicians, pharmacists, and ... clinical information to help ... decisions. Clinicians can trust ... because all information undergoes ...
... Derived from the trusted, ... database, this continually updated ... on thousands of commonly ... drugs and now includes ...
A handy, quick reference for physicians, nurses, and other health care providers treating cancer patients....
... updated for 2005, this practical handbook ... aspects of cancer chemotherapy. The book ... catalog of over 100 drugs both ... in cancer treatment. This new edition ...
Medicine Products: